It's also where the honesty has to come in
Specifically, we are finalizing our proposal to except the 24 proposed APCs that continue to have 2 times violations in this final rule with comment period data from the 2 times rule for CY 2024 claims data and also except three additional APCs that did not violate the 2 times rule in the CY 2026 OPPS/ASC proposed rule data, but do violate the 2 times rule in this final rule with comment period data, for a total of 27APCs for which we identified 2 times rule violations but that qualify for exceptions
And I guess with that as a transition, what Id like to help people with is Im assuming that people, when they first hear about peptides and then they hear about how many peptides there are, their heads spin
avoiding accidents and pile-ups
Adults 3060 with diabetic neuropathy or nerve-related conditions
Peptides can be safe when used appropriately under medical supervision, but they are not risk-free